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A B S T R A C T
Purpose: The objective of this study was to compare disease activity, impairments, disability, foot
function and gait characteristics between a well described cohort of juvenile idiopathic arthritis (JIA)
patients and normal healthy controls using a 7-segment foot model and three-dimensional gait analysis.
Methods: Fourteen patients with JIA (mean (standard deviation) age of 12.4 years (3.2)) and a history of
foot disease and 10 healthy children (mean (standard deviation) age of 12.5 years (3.4)) underwent
three-dimensional gait analysis and plantar pressure analysis to measure biomechanical foot function.
Localised disease impact and foot-speciﬁc disease activity were determined using the juvenile arthritis
foot disability index, rear- and forefoot deformity scores, and clinical and musculoskeletal ultrasound
examinations respectively. Mean differences between groups with associated 95% conﬁdence intervals
were calculated using the t distribution.
Results: Mild-to-moderate foot impairments and disability but low levels of disease activity were
detected in the JIA group. In comparison with healthy subjects, minor trends towards increased midfoot
dorsiﬂexion and reduced lateral forefoot abduction within a 3–58 range were observed in patients with
JIA. The magnitude and timing of remaining kinematic, kinetic and plantar pressure distribution
variables during the stance phase were similar for both groups.
Conclusion: In children and adolescents with JIA, foot function as determined by a multi-segment foot
model did not differ from that of normal age- and gender-matched subjects despite moderate foot
impairments and disability scores. These ﬁndings may indicate that tight control of active foot disease
may prevent joint destruction and associated structural and functional impairments.
 2012 Elsevier B.V.  
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Juvenile idiopathic arthritis (JIA) is a chronic and progressive
inﬂammatory arthritis of childhood which often results in
persistent and disabling foot impairments [1–3]. The primary
disease process – synovitis, has a predilection for the lower limb
joints and results in well-recognised clinical features including
joint pain, swelling, limited joint range-of-motion and develop-
ment of deformity [3–5]. Inﬂammatory pathology is not limited to
joints and studies employing musculoskeletal ultrasonography
have also detected tenosynovitis, enthesitis, and bursitis in the* Corresponding author at: School of Science and Health, University of Western
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Open access under CC BY-NC-ND license.periarticular ankle region [6]. Unsurprisingly disruption to global
gait patterns has been frequently reported as an early and common
consequence of JIA [7,8].
The impact of JIA on global function has been studied extensively
with the use of patient reported outcome measures (PROMs) such as
the childhood health assessment questionnaire (CHAQ), a widely
used 30 item measure of childhood disability [9,10]. Studies
employing PROMs have demonstrated strong associations between
clinical symptoms such as pain or radiographically detected joint
destruction, with poor long-term functional outcomes [11]. At a local
level, the impact of active disease and related impairments remain
unclear. The development of juvenile arthritis foot disability index
questionnaire (JAFI) [12], a 27 item measure organised by three
dimensions related to impairment, activity limitation, and partici-
pation restriction, has allowed researchers to quantify levels of
disease-related foot impairments and disability [1,2]. However
questions remain regarding its sensitivity and speciﬁcity particularly
during early stages of disease [2].
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ing of foot impairments in adults with rheumatoid arthritis (RA)
[13,14]. In particular, studies employing three-dimensional (3D)
multi-segmented foot models have demonstrated an ability to
quantify subtle but functionally important changes to foot
segment kinematics and kinetics at an early disease stage [15].
In contrast, little is known about the functional consequences of
active foot disease and/or residual impairments such as foot
deformity in patients with JIA.
Patients with JIA who have lower limb involvement tend to
walk slower, as a result of a reduced step length, reduced cadence
and an increased period of double limb support [2,16]. Reduced
peak pressures have been recorded in those with forefoot pain,
metatarso-phalangeal (MTP) joint and lesser toe deformity [17].
While elevated focal pressures in the forefoot have previously been
associated with pes cavus foot types [8]. Abnormal ankle-joint-
complex motion has been described where the foot has been
modelled as a single segment [7,16]. However this approach
provides limited information concerning other foot joint function
compared to the multi-segment approach [18]. Accordingly, the
aim of this study was to compare disease activity, impairments,
disability, foot function and gait characteristics between a well
described cohort of JIA patients and normal healthy controls using
a 7-segment foot model and 3D gait analysis.
2. Methods
2.1. Patient selection
Fourteen patients with a deﬁnitive diagnosis of JIA, based on the
International League of Associations for Rheumatology (ILAR)
criteria [19] were consecutively recruited from a phase II
randomised controlled trial of a multi-disciplinary foot-care
programme [20]. Participants had a documented history of active
inﬂammatory foot disease affecting the joints and/or soft tissues.
Ten community dwelling healthy children and adolescents
matched as closely as possible by age and gender, with no history
of trauma, neuromuscular or musculoskeletal diseases were
recruited for comparison. This study was approved by the Glasgow
West Local Research Ethics Committee on the 18th March 2008
(reference number 08/S0709/36). All participants and parents/
guardians provided their informed consent to participate in this
study.
2.2. Demographic, disease and clinical examination
Age, gender, body mass index, disease subtype, disease
duration, and current pharmacological therapy were recorded
for each patient. Functional health status was recorded using the
CHAQ [10]. Local disease impact was measured using the JAFI [12].
Localised disease activity was estimated by a podiatrist [GH] who
recorded tender and swollen joint scores in the foot for the ankle,
subtalar, calcaneocuboid, talonavicular, MTP, interphalangeal joint
of the hallux and proximal interphalangeal joints of the lesser toes
(range 0–14). Tender and swollen soft tissue sites in the foot were
also recorded for the tibialis posterior, ﬂexor digitorum longus,
ﬂexor hallucis longus, peroneus longus and peroneus brevis
tendons, the retro-calcaneal bursa (RCB), and the calcaneal
tendo-achilles (TA) and calcaneal plantar fascia entheses (PF)
(range 0–8). Fore- and rearfoot deformities were measured using
the structural index (SI) [21]. The SI summates hallux valgus, 5th
MTP exostosis, lesser toe deformities and MTP subluxation for the
forefoot (range 0–12) and calcaneal valgus/varus, ankle range of
motion and pes planus/cavus deformities of the rearfoot (range 0–
7). The weight-bearing varus/valgus alignment of the heel was
measured using a standard hand-held goniometer [15]. A fullytrained paediatric musculoskeletal ultra-sonographer [DET] inde-
pendently assessed localised disease activity in the foot. Those
joints from the clinical examination were assessed for effusion,
synovial hypertrophy (SH), and power Doppler signal (PDS).
Tendons were assessed for grey-scale features of ﬂuid within the
tendon sheath and PDS; the TA and PF for abnormal thickening, and
RCB for bursal effusion (bursitis). Standardised deﬁnitions for
ultrasound (US) -derived pathology (deﬁned by the outcome
measures in rheumatology 7 consensus statement) [22] were
employed throughout. US imaging was conducted using an Esaote
Mylab 25 Gold (Genova, Italy) with LA435 (10–18 MHz) probe
(footprint size 40 mm  10 mm). US features were recorded as
present/absent.
2.3. Biomechanical foot function
An 8 camera 120 Hz motion analysis system (Qualysis Oqus,
Gothenburg, Sweden) was used to track the motion of 25 surface-
mounted, spherical, and retro-reﬂective markers (5 mm and
10 mm diameter) placed on the shank and foot which were
positioned in order to represent the underlying skeletal structure.
This model was adapted from the original model proposed by
Hyslop et al. [23] previously to measure foot function in adults
with psoriatic arthritis (See supplementary online material for full
model description), and was selected for use on the basis that JIA is
an inﬂammatory arthropathy with similar disease features.
Visual3D software (C-motion, Inc., Rockville, MD, USA) was used
to build segmented foot models which comprised the shank, a
single foot segment, rearfoot, midfoot, lateral forefoot, 1st
metatarsal and hallux, based on the surface marker coordinates.
Ground reaction forces (120 Hz) and plantar pressure distributions
were measured separately using force (Kistler, Winterthur,
Switzerland) and pressure (Emed-X, Novel GmbH, Munich,
Germany) platforms. An instrumented walkway (GaitRite, CIR
systems, Clifton, NJ, USA) was used to measure spatial and
temporal gait parameters.
A pre-determined core set of foot biomechanical variables were
selected a priori for analysis based on previous survey and gait
analysis data in RA, psoriatic arthritis and JIA [2,13–15,23]. These
included walking velocity, cadence, step length, double support
time and cycle time as objective measures of global function.
Intersegment kinematics, kinetics and plantar pressure distribu-
tion parameters were selected to best capture the functional
changes associated with joint and soft-tissue damage in JIA. Initial
foot contact angle, rearfoot terminal stance range-of-motion in the
sagittal plane, peak vertical ground reaction forces, ankle joint
moment and ankle joint power were selected to describe the three
rocker functions of the foot [13,24]. Peak rearfoot eversion, peak
lateral forefoot abduction, peak 1st metatarsal dorsiﬂexion, peak
hallux dorsiﬂexion, minimum navicular height, midfoot and lesser
toe contact areas, and peak pressures in the rear- and forefoot were
selected to describe localised functional impairments, compensa-
tions and deformities [13,14]. The average velocity and duration of
the centre-of-pressure (CoP) throughout the foot, heel, midfoot,
forefoot and toe regions was recorded to quantify compensatory
foot-loading strategies associated with degraded and adapted
(antalgic) gait [25]. Peak midfoot dorsiﬂexion was selected for
exploratory analysis as both high- and low-arched midfoot posture
is a frequent clinical ﬁnding in JIA.
A relaxed standing (static) trial was collected for the foot from
each participant in order to deﬁne 08 (neutral) for the kinematic
data [26]. Kinematic and kinetic and parameters were collected
from 5 barefoot walking trials in each patient. Spatial and temporal
parameters were recorded from 5 barefoot self-selected walking
speed trials over the walkway. Plantar pressure distribution
parameters were collected separately from 5 barefoot trials using
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measurements were estimated from 5 trials of the right limb for all
participants. Automated software routines (Novel GmbH, Munich,
Germany) were used to deﬁne the rearfoot, midfoot, forefoot,
lesser toe and hallux regions of the foot for plantar pressure
distribution.
2.4. Statistical analysis
Statistical analyses were performed using SPSS 18.0 (SPSS Inc.
Chicago, IL, USA). Clinical and biomechanical variables were
summarised as mean and standard deviation (SD) or median
(range). The small sample size did not permit formal inferential
hypothesis testing, therefore mean differences between groups
and associated 95% conﬁdence intervals (CI) were calculated using
the t distribution [15]. Mean motion patterns of intersegment
kinematics were normalised to 101 time points (0–100% stance)
and both groups’ ensemble averages (1SD) were superimposed
and displayed graphically. Discrete gait variables were normalisedTable 1
Demographic and disease characteristics.
Patient Age (years) Gender BMI
(kg/m2)
JIA
subtype
Disease
duration
(years)
1 13 F 20.4 Other 3 
2 7 F 15.9 Ext oligo 6 
3 18 M 19.7 Poly+ 5 
4 11 F 15.0 Poly+ 2 
5 13 M 22.2 jPsA 2 
6 11 F 18.9 Poly 6 
7 14 M 28.4 ERA 5 
8 9 F 23.5 Oligo 8 
9 16 F 22.2 Poly 3 
10 10 F 14.5 jPsA 5 
11 17 F 20.0 Poly 13 
12 9 F 15.0 Oligo 7 
13 14 F 24.9 jPsA 7 
14 12 M 16.5 Poly 2 
Summary values 12.4 (3.2) 10:4 19.8 (4.0) – 5.3 (3.0) 
Reference values 12.5 (3.4) 6:4 19.8 (3.6) – – 
BMI: body mass index; DMARD: disease modifying anti-rheumatic drug; CHAQ: childhoo
impairment; al: activity limitation; pr: participation restriction; Ext oligo: extended oligo
negative polyarthritis; jPsA: juvenile psoriatic arthritis; ERA: juvenile enthesitis relate
factor alpha; ICI: intra-articular corticosteroid injection.
Table 2
Disease and clinical characteristics.
Patient TJC (0–14) SJC (0–14) TSTC (0–8) SSTC (0–8) U
1 1 3 0 1 5
2 0 0 0 0 0
3 4 0 0 0 7
4 0 0 0 0 3
5 0 0 5 5 0
6 0 0 0 0 2
7 1 1 3 2 2
8 0 0 1 3 0
9 0 0 0 0 0
10 0 0 0 0 0
11 0 2 0 7 6
12 3 3 3 3 3
13 5 2 2 0 4
14 2 2 0 0 0
Summary values 0 (0–5) 0 (0–3) 0 (0–5) 0 (0–7) 3
Reference values 0 0 0 0 0
TJC: tender joint counts; SJC: swollen joint counts; TSTC: tender soft tissue counts; SSTC: s
FF: forefoot structural inxex; SI RF: rearfoot structural index; RSFP: relaxed standing f
* Mean (standard deviation), all other summary and reference values = median (rangwhere appropriate to dimensionless quantities using the formulae
described by Hof [28].
3. Results
3.1. Demographic and clinical characteristics
Demographic, disease and clinical characteristics are sum-
marised in Tables 1 and 2. Fourteen JIA patients (10 female, 4
male) with a mean age of 12.4 years (SD 3.2) were studied. This
was a heterogeneous sample including patients with variable JIA
disease subtype, disease duration and medication. All patients
were in receipt of disease-modifying anti-rheumatic drugs
(DMARDs) and/or biologic therapies. Ten control subjects (6
female, 4 male) with a mean age of 12.5 years (SD 3.4) were
studied for comparison. Control subjects were closely matched to
JIA case subjects by age and BMI, but had a greater proportion of
M:F than the JIA subjects. Functional impairment scores (CHAQ)
were typically in the mild-to-moderate category (>0.13 to <0.63)DMARD CHAQ (0–3) JAFIIMP (0–4) JAFIAL (0–4) JAFIPR (0–4)
MTX, TNFa 1.75 2 3 1
MTX, TNFa 0.125 0 1 0
Abatacept 1.125 3 2 3
MTX, TNFa 0.25 1 0 0
MTX, ICI 0 1 0.5 1.5
MTX, TNFa 1 1 2 2.5
TNFa 0.625 2 2 2
Adalimumab 0.625 1 1 1.5
MTX, TNFa 0.25 1 1 1.5
Adalimumab 0.5 2 2 2.5
Adalimumab 0 1 1 1
MTX, ICI 0.125 2 1 1.5
MTX 0.375 0 0 0
MTX, TNFa 1.25 2 1 2
– 0.4375 (0–1.75) 1 (0–3) 1 (0–3) 1.5 (0–3)
– 0 (0) 0 (0–1) 0 0
d health assessment questionnaire; JAFI: juvenile arthritis foot disability index; imp:
arthritis; Poly+: rheumatoid factor positive polyarthritis; Poly: rheumatoid factor
d arthritis; Oligo: oligoarthritis, MTX: methotrexate; TNAa: anti-tumour necrosis
SEFF (0–14) USSYN (0–14) SI FF (0–12) SI RF (0–7) RSFP (8)
 0 0 4 10
 0 0 2 2
 0 5 5 25
 0 3 4 10
 0 0 5 8
 2 2 2 10
 0 0 3 3
 0 1 3 5
 0 2 2 3
 0 0 4 15
 2 2 2 5
 2 0 5 11
 2 2 2 4
 1 0 4 7
 (0–7) 0 (0–2) 0.5 (0–5) 3.5 (2–5) 7.0 (7.8)*
 0 0 0.5 3.2 (3.2)*
wollen soft tissue counts; USEFF: ultrasound effusion; USSYN: ultrasound synovitis; SI
oot posture (negative value: valgus, positive value: varus).
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Fig. 1. Selected kinematic- and kinetic-time curves over 100% of the stance phase of gait (x-axis) for patients with JIA (black line with error bars represents mean  1 standard
deviation) versus controls (grey shaded area represents mean  1 standard deviation). (A) Rearfoot frontal plane motion; (B) rearfoot sagittal plane motion; (C) navicular height; (D)
midfoot sagittal plane motion; (E) 1st metatarsal sagittal plane motion; (F) lateral forefoot transverse plane motion; (G) hallux sagittal plane motion; (H) ankle joint power and (I)
ankle joint moment.
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moderate impairment.
JAFI scores for localised foot impairments and disability were in
the mild-to moderate category (1 to 2) but were variable
between JIA subjects. Median (range) scores for each domain were
1 (0–3) (impairment and activity limitation) and 1.5 (0–3)
(participation restriction). There were low levels of clinically
detected disease activity in the joints and soft tissues as indicated
by tender and swollen joint and soft tissue counts. Foot joint
effusions detected using US were a typical ﬁnding in patients with
JIA, suggesting that subclinical disease was present in several
patients. Mild forefoot and moderate rearfoot deformities were
recorded in patients with JIA, who typically exhibited a marginally
more valgus foot posture than controls.
3.2. Gait analysis
Ensemble average kinematic-time and kinetic-time variables
are summarised in Fig. 1 and core biomechanical variables in Table
3. The magnitude and timing of the kinematic and kinetic variables
during the stance phase of gait were similar for both groups. The
average patterns for the JIA patients did not deviate outside normal
limits (Fig. 1). Trends were observed for reduced peak ankle joint
plantarﬂexor moment, joint power, and the peak vertical ground
reaction force at initial contact and terminal stance in the children
with JIA, however 95% CIs of the mean differences for each variable
crossed zero (Table 3). No difference could be detected for in the
initial and terminal stance contact angles for the foot relative to
the ground. Medial longitudinal arch posture, as indicated by the
navicular height, was not different between the two groups. The
rearfoot ROM and peak eversion and 1st metatarsal dorsiﬂexionwere the same in both groups. The JIA group showed trends
towards slight increases in midfoot dorsiﬂexion (95% CI of mean
differences did not cross zero), reductions in lateral forefoot
abduction and decreases in peak hallux dorsiﬂexion (95% CIs of
mean differences crossed zero). However these differences on
average were small and in the 3–58 range.
The distribution of plantar pressure was not different between
the two groups in terms of midfoot and lesser toe contact areas
(Table 3). Pressure in the rearfoot, 1st metatarsal and lateral
forefoot regions were on average 35 kPa and 43 kPa lower
respectively, and 1 kPa respectively higher in the children with
JIA. However 95% CIs of mean differences included zero suggesting
a minor trend only. The JIA children walked with a reduced step
length, reduced walking velocity, and increased cadence, in
comparison with control subjects although double-support time
was unaffected (Table 3). The average velocity of the COP through
the foot regions was similar for both groups (Table 4). The duration
of the COP was slightly increased in the midfoot and slightly
decreased in the forefoot regions in the JIA patients in comparison
with control subjects.
4. Discussion
This is the ﬁrst study to report selected 3D kinematics and
kinetics, spatio-temporal parameters, and plantar pressure distri-
bution in a group of JIA children and adolescents in receipt of
optimised medical management. Results indicate only small
changes in foot function consistent with degraded and adapted
gait. These ﬁndings are in contrast to past studies which have
shown marked changes in foot function [3,4,7,8,16]. In an era of
optimal medical management exploiting DMARD and biological
Table 3
Gait analysis variables with group mean differences and associated 95% conﬁdence intervals.
Core biomechanical variables JIA Controls Mean difference (95% CI)
Kinematic/kinetic variables
Peak ankle joint moment (Nm/kg) 1.37 (0.15) 1.45 (0.22) 0.09 (0.24, 0.07)
Norm peak ankle joint moment 0.005 (0.002) 0.006 (0.002) 0.0004 (0.001, 0.002)
Peak ankle joint power (W/kg) 1.89 (0.83) 2.17 (0.89) 0.28 (0.45, 1.01)
Norm ankle joint power 0.005 (0.003) 0.004 (0.002) 0.0003 (0.003, 0.002)
Peak force initial contact (BW) 1.06 (0.07) 1.08 (0.13) 0.02 (0.64, 0.10)
Norm force initial contact 0.003 (0.001) 0.003 (0.001) 0.0004 (0.001, 0.001)
Peak force terminal stance (BW) 1.08 (0.07) 1.11 (0.09) 0.04 (0.03, 0.10)
Norm force terminal stance 0.003 (0.001) 0.003 (0.001) 0.0002 (0.001, 0.001)
Initial contact angle (8) 16.9 (3.4) 17.4 (3.0) 0.5 (2.3, 3.3)
Terminal stance angle (8) 51.5 (7.4) 52.4 (10.6) 0.8 (8.4, 6.8)
Minimum navicular height (mm) 34 (11) 35 (8) 2 (7, 10)
Peak rearfoot eversion (8) 8.0 (5.7) 7.0 (5.6) 1.0 (3.9, 5.9)
Rearfoot terminal stance ROM (8) 12.1 (4.4) 12.7 (6.2) 0.6 (3.9, 5.0)
Peak midfoot dorsiﬂexion (8) 7.3 (3.5) 4.3 (2.7) 3.0 (5.8, 0.3)
Peak 1st met dorsiﬂexion (8) 12.6 (7.8) 11.7 (4.2) 0.9 (4.7, 6.6)
Peak lateral forefoot abduction (8) 5.5 (5.2) 9.1 (4.1) 3.6 (7.7, 0.5)
Peak hallux dorsiﬂexion (8) 58.0 (13.7) 62.3 (12.2) 4.3 (6.9, 15.6)
Pressure variables
Midfoot contact area (cm2) 19.0 (12.3) 19.0 (4.5) 0.0 (8.5, 8.4)
Lesser toes contact area (cm2) 7.6 (2.3) 7.5 (3.3) 0.2 (2.5, 2.2)
Rearfoot peak pressure (kPa) 320 (90) 355 (113) 35 (51, 121)
1st metatarsal peak pressure (kPa) 281 (103) 325 (179) 43.3 (76, 163)
Lateral forefoot peak pressure (kPa) 248 (180) 247 (62) 1.1 (125, 122)
Spatiotemporal parameters
Step length (cm) 59.9 (6.5) 63.4 (9.9) 3.5 (3.5, 10.4)
Norm step length (cm) 0.7 (0.1) 0.8 (0.1) 0.0 (0.1, 0.1)
Double support time (%GC) 19.8 (4.3) 19.0 (3.3) 0.7 (4.1, 2.6)
Cycle time (s) 1.1 (0.2) 1.1 (0.1) 0.0 (0.1, 0.1)
Walking velocity (cm/s) 108.0 (17.2) 115.8 (20.7) 7.8 (8.3, 23.9)
Norm walking velocity 38.5 (7.3) 40.6 (6.3) 2.1 (3.8, 8.0)
Cadence (steps/min) 128.2 (45.8) 118.6 (11.1) 9.7 (40.5, 21.2)
Norm cadence 36.6 (11.8) 34.3 (3.4) 3.9 (10.2, 5.8)
CI: conﬁdence interval; BW: body weight; ROM: range of motion; GC: gait cycle; Norm: dimensionless normalisation [28].
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control of active foot disease prevents or reduces the frequency and
severity of joint destruction and the associated structural and
functional impairments.
The patients with JIA described in this study were heteroge-
neous for age, disease subtype and disease duration. With
established disease the majority were treated with a biological
agent and/or methotrexate. This optimised medical approach
appears to have lessened the overall foot disease burden as
indicated by low levels of self/parent-reported pain, functional
loss and disability. Ultrasound examination indicated on-going
active disease in approximately one-third of children. However,
it is acknowledged that signiﬁcant discrepancies still exist
between clinical and US examinations of foot disease in JIA [6].Table 4
Regionalised centre-of-pressure analysis with group mean differences and
associated 95% conﬁdence intervals.
Variable Region JIA
(n = 14)
Controls
(n = 10)
Mean difference
(95% CI)
VCoPave (m/s) Foot 0.28 (0.03) 0.31 (0.05) 0.03 (0.01, 0.06)
Heel 0.26 (0.08) 0.30 (0.09) 0.04 (0.04, 0.11)
Midfoot 0.42 (0.13) 0.48 (0.08) 0.06 (0.03, 0.15)
Forefoot 0.22 (0.04) 0.22 (0.05) 0.00 (0.04, 0.04)
Toes 0.67 (0.25) 0.69 (0.24) 0.02 (0.19, 0.23)
DCoP
(% stance)
Heel 24.9 (6.1) 24.8 (6.2) 0.2 (5.5, 5.1)
Midfoot 21.5 (6.9) 19.2 (4.1) 2.3 (7.4, 2.7)
Forefoot 46.2 (9.3) 48.5 (5.3) 2.4 (4.4, 9.2)
Toes 7.3 (3.2) 7.5 (2.3) 0.12 (2.3, 2.7)
VCoPave (m/s): average velocity of the centre of pressure; DCoP (% stance): duration
of the centre of pressure; CI: conﬁdence interval.Despite this detailed analysis of foot function revealed only
subtle changes some indicative of degraded and some of adapted
gait. By contrast, studies reported in the pre-biological and tight
control era, often where disease factors and treatment regimes
are not reported, demonstrate marked degenerative and adapted
gait disturbances [7,8,16,17,30]. These include changes to overall
gait pattern characterised by reduced walking velocity and
shortened step and stride length [16] altered load and pressure
distribution characteristic of both high-arch and ﬂat-foot posture
[8]; disturbance of the normal sagittal rocker function [17,30];
and muscle imbalance and reduced muscle strength [7,30]. In
terms of joint kinematics, reduced ankle plantarﬂexion in
terminal stance has been demonstrated where the foot was
modelled as a single segment [16]. In many of these studies there
is little or no information provided on disease subtype, disease
activity, active joint disease, morbid foot state, or medical and
non-pharmacological interventions making direct comparisons
difﬁcult. However, Dekker et al. [1] demonstrated strong
relationships between disease activity and foot-related impair-
ments and disability using the JAFI questionnaire. The JAFI
scoring system may be vulnerable to a moderate ﬂoor effect,
resulting in insensitivity for detecting impairments [2]. Never-
theless in the present study active disease was low and this was
associated with low levels of self-reported foot impairment and
functional disability measured using the JAFI. This study adds
additional evidence suggesting the articular function in the foot
can be well preserved when disease activity is suppressed using
optimised medical care.
In other inﬂammatory joint diseases, in particular rheumatoid
arthritis, marked changes in foot function has been demonstrated
in a number of studies in both early and established disease
G.J. Hendry et al. / Gait & Posture 38 (2013) 30–36 35[13–15]. The failure to detect important functional changes in the
JIA group in comparison can be explained by the cumulative
effects of destructive joint disease in the RA patients who, in most
studies, have longer disease duration and sub-optimal drug
management. However, even in JIA patients the lag time in which
to gain optimised case with disease remission or low disease state
can take time and in that time joint and soft-tissue damage can
occur. Subtle changes were observed in the present study
including reduced walking speed and some changes to mid-foot
arch posture. At the individual patient level some children did
have marked impairments and this would indicate that on-going
studies, in particular inception cohort designs from onset of
symptoms/diagnosis are warranted to understand disease
progression across all subtypes.
There are a number of limitations to this study. Firstly the
sample size is small and the inclusion of all disease subtypes
precludes wider generalisation of the ﬁndings. Secondly, the foot
model was developed and tested in adults with inﬂammatory joint
disease [23]. Landmark identiﬁcation around the rearfoot, in
particular, the peroneal tubercle, the dorso-lateral apex of the
cuboid, and the dorsal aspect of the intermediate cuneiform was
challenging. As such the rear- and mid-foot segment rotation data
may have been vulnerable to errors different from those reported
for the original model. We attempted to limit this by using one
experienced paediatric clinician with experience in multi-segment
foot model use in disease populations. Utilising a similar protocol
with adult subjects with and without psoriatic arthritis Hyslop
et al. [23] demonstrated excellent within-day and between-day
reliability characteristics for spatio-temporal, plantar pressure,
kinematic and kinetic variables. However peak rearfoot eversion
performed poorly [23] with within-group variance exceeding
between group variance. Therefore comparison between cases and
controls for peak rearfoot eversion in the present study may be
vulnerable to error, particularly since this is the ﬁrst application of
the model to measure children and adolescents’ with and without
JIA. Furthermore, the shortage of control subjects due to time
constraints resulted in an imbalance when matching cases (n = 14)
to controls (n = 10). As a result, group means from heterogeneous
groups were compared via an independent t test as opposed to the
preferred paired t test, which may have reduced the validity of the
comparative analysis. Lastly it is acknowledged that the plantar
pressure region identiﬁcation software is not operator indepen-
dent and may be vulnerable to variability.
5. Conclusion
In conclusion, in this optimally medically managed sample of
children with JIA, foot function as determined by a multi-segment
foot model, did not differ from that of normal age- and sex-
matched subjects. This was in spite of many patients reporting
mild-to-moderate levels of foot-related impairments and disabili-
ty via the JAFI. Further work is necessary to extend and conﬁrm
these observations in speciﬁc subtypes linked with close assess-
ment of underlying joint and soft-tissue pathology and foot-related
impairment and disability.
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